Advisors Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Advisors Asset Management's HALO Position: Q2 2026 in Review
Advisors Asset Management reduced its Halozyme (HALO) stake by 64% in Q2 2026, selling an estimated $785K and leaving 6,353 shares worth $497K. The position accounts for 0.01% of the portfolio, ranked #988.
Advisors Asset Management first reported a position in HALO in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.5M in Q4 2022. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Advisors Asset Management held 6,353 shares of Halozyme worth $497K as of Q2 2026.
- Advisors Asset Management sold 11,513 Halozyme shares in Q2 2026, an estimated $785K.
- Halozyme made up 0.01% of Advisors Asset Management's portfolio in Q2 2026, its #988 holding.
- Advisors Asset Management first reported a position in Halozyme in Q2 2020 and has held it in 25 quarters since.
- Advisors Asset Management's Halozyme position peaked at $2.5M in Q4 2022.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.